Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
European Urology|August 25, 2019
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateMarko Babjuk, Maximilian Burger, Eva M Compérat, et al.
Brain : a Journal of Neurology|July 2, 2025
Biomarker evidence of neurodegeneration in mid-life former rugby playersNeil S N Graham, Karl A Zimmerman, Jessica Hain, et al.
European Urology|March 21, 2020
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder CancerHugh Mostafid, Marko Babjuk, Bernard Bochner, et al.
Lancet (London, England)|September 5, 2006
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisJean Bourhis, Jens Overgaard, Hélène Audry, et al.
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
The Cochrane Database of Systematic Reviews|December 15, 2010
Hyperfractionated or accelerated radiotherapy for head and neck cancerBertrand Baujat, Jean Bourhis, Pierre Blanchard, et al.
The New England Journal of Medicine|August 9, 2002
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosisRaoul Herbrecht, David W Denning, Thomas F Patterson, et al.
BMJ Open|December 9, 2023
Specialist healthcare services for concussion/mild traumatic brain injury in England: a consensus statement using modified Delphi methodologyElika Karvandi, Adel Helmy, Angelos G Kolias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer GroupAshish M Kamat, Andrea B Apolo, Marek Babjuk, et al.
World Journal of Urology|March 13, 2021
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancerDavid D'Andrea, Francesco Soria, Anne J Grotenhuis, et al.
Pageof 9